Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
109.81
+4.04 (3.82%)
At close: Jun 11, 2026, 4:00 PM EDT
109.79
-0.02 (-0.02%)
After-hours: Jun 11, 2026, 4:00 PM EDT
Protagonist Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $106 → $113 | Buy | Maintains | $106 → $113 | +2.91% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $117 | Buy | Reiterates | $117 | +6.55% | May 11, 2026 |
| Citi | Citi | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | +18.39% | May 10, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $120 → $137 | Buy | Maintains | $120 → $137 | +24.76% | May 7, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $97 → $110 | Hold | Maintains | $97 → $110 | +0.17% | May 7, 2026 |
| Wedbush | Wedbush | Buy Reiterates $112 → $118 | Buy | Reiterates | $112 → $118 | +7.46% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains $119 | Buy | Maintains | $119 | +8.37% | May 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $100 | Buy | Maintains | $100 | -8.93% | May 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.